Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reha-Baris Incesu

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Urologic Oncology|August 9, 2023
Conditional survival of stage III non-seminoma testis cancer patientsReha-Baris Incesu, Francesco Barletta, Stefano Tappero, et al.
Cancers|December 11, 2022
Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological SubtypeFrancesco Barletta, Stefano Tappero, Andrea Panunzio, et al.
Clinical Genitourinary Cancer|December 2, 2023
Other-Cause Mortality, According to Partial vs. Radical Nephrectomy: Age and Stage AnalysesAndrea Baudo, Reha-Baris Incesu, Simone Morra, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 28, 2023
Differences in overall survival of penile cancer patients versus population-based controlsLukas Scheipner, Stefano Tappero, Mattia Luca Piccinelli, et al.
Cancer Epidemiology|February 20, 2024
Survival differences in non-seminoma testis cancer patients according to race/ethnicityReha-Baris Incesu, Francesco Barletta, Stefano Tappero, et al.
Surgical Oncology|November 4, 2025
Sarcomatoid dedifferentiation as a predictor of overall mortality in surgically treated metastatic renal cell carcinomaReha-Baris Incesu, Lukas Scheipner, Simone Morra, et al.
Cancers|February 11, 2023
Survival of Testicular Pure Teratoma vs. Mixed Germ Cell Tumor Patients in Primary Tumor Specimens across All StagesCristina Cano Garcia, Francesco Barletta, Reha-Baris Incesu, et al.
Urologic Oncology|November 13, 2024
Primary tumor ablation in metastatic renal cell carcinomaLukas Scheipner, Reha-Baris Incesu, Simone Morra, et al.
Journal of Surgical Oncology|August 26, 2024
Effect of race/ethnicity on survival in surgically treated intermediate/high risk non-metastatic clear cell renal carcinomaMattia Luca Piccinelli, Cristina Cano Garcia, Andrea Panunzio, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 5, 2024
Improved Survival in Contemporary Community-Based Patients With Metastatic Clear-Cell Renal Cell Carcinoma Undergoing Active TreatmentReha-Baris Incesu, Simone Morra, Lukas Scheipner, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Urologic Oncology|August 9, 2023
Conditional survival of stage III non-seminoma testis cancer patientsReha-Baris Incesu, Francesco Barletta, Stefano Tappero, et al.
Cancers|December 11, 2022
Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological SubtypeFrancesco Barletta, Stefano Tappero, Andrea Panunzio, et al.
Clinical Genitourinary Cancer|December 2, 2023
Other-Cause Mortality, According to Partial vs. Radical Nephrectomy: Age and Stage AnalysesAndrea Baudo, Reha-Baris Incesu, Simone Morra, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 28, 2023
Differences in overall survival of penile cancer patients versus population-based controlsLukas Scheipner, Stefano Tappero, Mattia Luca Piccinelli, et al.
Cancer Epidemiology|February 20, 2024
Survival differences in non-seminoma testis cancer patients according to race/ethnicityReha-Baris Incesu, Francesco Barletta, Stefano Tappero, et al.
Surgical Oncology|November 4, 2025
Sarcomatoid dedifferentiation as a predictor of overall mortality in surgically treated metastatic renal cell carcinomaReha-Baris Incesu, Lukas Scheipner, Simone Morra, et al.
Cancers|February 11, 2023
Survival of Testicular Pure Teratoma vs. Mixed Germ Cell Tumor Patients in Primary Tumor Specimens across All StagesCristina Cano Garcia, Francesco Barletta, Reha-Baris Incesu, et al.
Urologic Oncology|November 13, 2024
Primary tumor ablation in metastatic renal cell carcinomaLukas Scheipner, Reha-Baris Incesu, Simone Morra, et al.
Journal of Surgical Oncology|August 26, 2024
Effect of race/ethnicity on survival in surgically treated intermediate/high risk non-metastatic clear cell renal carcinomaMattia Luca Piccinelli, Cristina Cano Garcia, Andrea Panunzio, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 5, 2024
Improved Survival in Contemporary Community-Based Patients With Metastatic Clear-Cell Renal Cell Carcinoma Undergoing Active TreatmentReha-Baris Incesu, Simone Morra, Lukas Scheipner, et al.
Pageof 7